The trial will take place at a Kaiser Permanente research facility in Washington state.
It will take a year to 18 months to validate the vaccine.
The National Institutes of Health is funding the study.
The Associated Press contributed to this report.
In Other News
1
17-year-old killed in Springfield crash, teen passenger injured
2
‘We want to encompass the whole community’: Building Block Play Studio...
3
Clark State College celebrates class of 2025 with over 500 graduates
4
Tax elimination ballot initiative gets Ohio AG’s approval
5
State-wide arts conference chooses Hamilton for 2026 location
About the Author